Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Latest News

Date	Subject	Media
2026-05-28	NCCN Grants Category 1 Status to PharmaEssentia’s Ropeg for Essential Thrombocythemia (ET)	Commercial Times
2026-05-28	StemCyte Receives US Government Grant Extension Through 2027 for Multi-Ethnic Cord Blood Program	Investor
2026-05-28	Ministries of Environment and Health Convene Joint Committee to Protect Vulnerable Populations	Economic Daily News
2026-05-28	TaiGen Biopharmaceuticals Licenses Flu Candidate Pixavir to Boryung for South Korean Market	Economic Daily News
2026-05-28	Formosa Pharmaceuticals to Relaunch Ophthalmic New Drug BICOVI in the US; Targets 50% Market Share	Investor
2026-05-28	HealthConn Advances Microbial Diagnostics with New "Reflex" Laboratory in Taichung	Investor
2026-05-26	Lin BioScience (Belite Bio) Completes Enrollment for LBS-008 Phase II/III DRAGON II Trial for Stargardt Disease	Economic Daily News
2026-05-26	SciVision Biotech Secures Kuwaiti Sales License for Hyaflex™ Joint Injections	Economic Daily News
2026-05-26	Gongwin Biopharm Reports Breakthrough Clinical Results for Equine Oncology at WEVA 2026	Commercial Times
2026-05-26	Taiwan Extends Hospital Accreditation Validity to 6 Years; Smart Healthcare and Workplace Quality to be Integrated	China Times

■ Most Watched

■ Industry Watch

■ IBMI News

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978